Thesis Abstract

Abstract
The prevalence of Type 2 Diabetes Mellitus (T2DM) is increasing globally, posing a significant public health challenge. Gut health has emerged as a critical factor in the management of T2DM, with growing interest in the potential therapeutic role of probiotics supplementation. This thesis investigates the impact of probiotics supplementation on gut health in individuals with T2DM. The study aims to evaluate the effects of probiotics on glycemic control, inflammatory markers, gut microbiota composition, and overall health outcomes in T2DM patients. Chapter 1 provides an introduction to the research topic, highlighting the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. Chapter 2 presents a comprehensive literature review on probiotics, gut health, T2DM, and the interplay between them. The review synthesizes current evidence on the effects of probiotics on glycemic control, inflammation, gut microbiota, and other relevant outcomes in T2DM patients. Chapter 3 outlines the research methodology, including the study design, participant selection criteria, intervention details, outcome measures, data collection procedures, and statistical analysis plan. The chapter also discusses ethical considerations and potential biases in the study. Chapter 4 presents a detailed analysis and discussion of the findings, focusing on the impact of probiotics supplementation on gut health parameters and clinical outcomes in individuals with T2DM. The results reveal the potential benefits of probiotics in improving glycemic control, modulating inflammatory markers, and promoting a healthier gut microbiota profile in T2DM patients. Furthermore, the study identifies specific probiotic strains and dosages that may be most effective in this population. Chapter 5 concludes the thesis by summarizing the key findings, discussing their implications for clinical practice and future research directions, and providing recommendations for healthcare providers and policymakers. Overall, this thesis contributes to the growing body of evidence supporting the use of probiotics as a complementary therapy for individuals with T2DM. The findings underscore the importance of gut health in diabetes management and highlight the potential of probiotics supplementation as a safe and cost-effective intervention to improve health outcomes in this population.

Thesis Overview